A press release has been issued by Wave Life Sciences Ltd.
- Business
Announcement Date: December 19, 2022 (U.S. Time)
detail: Our key investment, Wave Corporation, has announced the development status of their pipeline WVE-N531, which targets Duchenne muscular dystrophy. Details are Here please refer to the original press release.